Abstract: Disclosed is a battery cell including an electrode, a housing, a cell interior inside the housing, a temperature sensor, and a heat-conducting part which differs from the electrode, is entirely or partially disposed inside the housing of the battery cell, and is thermally connected to the temperature sensor.

Abstract: A method for changing software data of a field device is disclosed. In an embodiment, the field device has, in or on a housing, a device code that can be optically detected using a mobile device. An embodiment of the method includes detecting a first device code with a reader unit of the mobile device, accessing primary device data of the field device by the mobile device, and converting the primary device data to secondary device data. The embodiment further includes detecting a second device code and subsequently transmitting the secondary device data to the field device. The second device code may be the same as or different from the first device code. The disclosed embodiments furthermore comprise an associated system.

Abstract: The present application relates to an aqueous pharmaceutical composition for use as a paediatric medicament in the treatment or prevention of vitamin A deficiency or a vitamin A deficiency-associated disease.

Abstract: The present invention relates to an aqueous composition comprising apomorphine or a pharmaceutically acceptable salt or solvate thereof, reduced glutathione (GSH) or a pharmaceutically acceptable salt thereof, and ascorbic acid or a pharmaceutically acceptable salt or derivative thereof, wherein the composition has a pH of about 3 to about 7.4. The aqueous composition according to the invention exhibits superior tolerability and an improved side effect profile, particularly a reduced occurrence of skin nodule formation and panniculitis, when administered subcutaneously. The invention further relates to the composition for use as a medicament, particularly for the treatment of Parkinson's disease.